Cadrenal Therapeutics (CVKD) PT Lowered to $13 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts CVKD Hot Sheet
Price: $1.32 +17.86%
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis lowered the price target on Cadrenal Therapeutics (NASDAQ: CVKD) to $13.00 (from $32.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Defending Shopify (SHOP) Amid Heavy Selling Day: 'Muse Headlines Offer Buying Opportunity'
- Biman Bangladesh orders 11 more Boeing jets in second 2026 deal
- Everpure raises FY28 revenue outlook, targets four growth areas
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
